I e-mailed Mr. cook yesterday and he was nice enough to answer this A.M. He said the merge is still on and that the proxy statement was sent to the SEC today. He also said news would be forth-coming soon, I can only pray that it will be something positive for epicept shareholders.
This is from the proxy:
NOTICE IS HEREBY GIVEN, that a Special Meeting of the Stockholders (the “Meeting”) of EpiCept Corporation (the “Company”, “EpiCept”, “we” or “us”) will be held on [ ] at [ ] local time, at [ ], to (i) amend the Company’s Third Amended Certificate of Incorporation, as amended (the “Certificate of Incorporation”) to effect a reverse stock split of its outstanding common stock at a ratio of one-for-forty, subject to adjustment by our board of directors (the “Board of Directors”), immediately prior to the closing of the proposed merger with Immune Pharmaceuticals Ltd.; (ii) amend the Certificate of Incorporation to change the Company’s name to “Immune Pharmaceuticals Inc.” upon completion of the proposed merger with Immune Pharmaceuticals Ltd.; (iii) grant discretionary authority to the persons named as proxies to adjourn the Meeting if necessary to solicit additional proxies in the event there are insufficient votes to approve the first two proposals; and (iv) transact such other business as may properly come before the Meeting or any adjournment or adjournments thereof.
No date for the meeting, but it has all the important stuff. Did we know about the 1-for-40 reverse split?
It was going to be some kind of reverse split, remember epct is broke, but they have some very promising drugs in different stages of approval and immune is taking advantage of that fact, I still believe Amiket is in the mix more than we know, but will find out after merger, Immune did not become part of this unless they saw something with some potential right off the get-go. Good Luck all.
The announcement said they started mailing out the proxies yesterday, so we should be receiving them soon. The meeting is in August. It's a 1 for 40 reverse split, with fractional shares rounded up to a whole number.